Nail Biting Pharmacotherapy: a Review

AbstractPurposeOnychophagia, or habitual nail biting, is a common disorder, especially in children and young adults. Multiple factors contribute to its development, from emotional triggers to genetics and underlying psychiatric conditions. Nail biting can have a significant impact on one ’s quality of life, and its complications are not limited to cosmetic distortion. In severe cases, uncontrolled onychophagia can cause serious physical, dental, and psychosocial consequences. In this article, we review the use of N-acetyl cysteine (NAC), selective serotonin reuptake inhibitors (SS RIs), tricyclic antidepressants (TCAs), lithium, and silymarin as possible treatment modalities for chronic nail biting.Recent FindingsThere are many established behavioral and psychological interventions for the treatment of onychophagia, albeit modest in efficacy. And up until today, there is minimal evidence that supports effective pharmacotherapy. However, several of these drugs show promising results that warrant further exploration.SummaryNAC was found to be more effective than placebo in the short term, while SSRIs showed contradictory results. TCAs (especially clomipramine), lithium, and silymarin have also exhibited potential in curbing nail biting behavior to different extents. Further studies are required to outline a definite treatment modality for onychophagia, along with corresponding therapeutic doses.
Source: Current Treatment Options in Psychiatry - Category: Psychiatry Source Type: research